太阳集团tyc5997_平台(china)官方网站

胃泌素抑制肽(GIP)单克隆抗体

Monoclonal Antibody to Gastric Inhibitory Polypeptide (GIP)

Incretin hormone; Glucose Dependent Insulinotropic Peptide

  • 编号MAA882Mi21
  • 物种Homo sapiens (Human，人), Mus musculus (Mouse，小鼠), Rattus norvegicus (Rat，大鼠), Cavia (Guinea pig ，豚鼠), Rhesus monkey (Simian，恒河猴), Canis familiaris; Canine (Dog，犬), Sus scrofa; Porcine (Pig，猪), Bos taurus; Bovine (Cattle，牛) 相同的名称，不同的物种。
  • 来源单抗制备
  • 宿主小鼠
  • 效价(克隆号)A6
  • Ig亚型 N/A
  • 纯化方式蛋白A + 蛋白G亲和纯化
  • 标记物无标记物
  • 免疫原 -
  • 缓冲液成份0.01M 磷酸盐缓冲液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
  • 性状液体
  • 浓度1mg/mL
  • 且适物种-
  • 应用WB; IHC; ICC; IP.
    如果抗体需用于流式细胞术，请参见流式抗体。
  • 下载 英文说明书   中文说明书
  • 规格 20µl100µl 200µl 1ml 10ml
  • 价格 ¥ 605 ¥ 1411 ¥ 2016 ¥ 5040 ¥ 20160
  • 欲了解实际交易价格和更多情况，请与当地经销商联系!
  • 胃泌素抑制肽(GIP)单克隆抗体 产品包装(模拟)
  • 胃泌素抑制肽(GIP)单克隆抗体 产品包装(模拟)
  • 胃泌素抑制肽(GIP)单克隆抗体 DAB staining on IHC-P; Samples: Human Stomach Tissue; Primary Ab: 30µg/ml Mouse Anti-Multi-species GIP Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对GIP的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别GIP。

用法

Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号 适用物种：Homo sapiens (Human，人), Mus musculus (Mouse，小鼠), Rattus norvegicus (Rat，大鼠), Cavia (Guinea pig ，豚鼠), Rhesus monkey (Simian，恒河猴), Canis familiaris; Canine (Dog，犬), Sus scrofa; Porcine (Pig，猪), Bos taurus; Bovine (Cattle，牛) 应用(仅供研究使用，不用于临床诊断！)
MAA882Mi21 胃泌素抑制肽(GIP)单克隆抗体 WB; IHC; ICC; IP.
MAA882Mi28 胃泌素抑制肽(GIP)单克隆抗体 WB; IHC; ICC; IP.

参考文献

杂志 参考文献
Scientific Reports The anti-hyperglycemic efficacy of a lipid-lowering drug Daming capsule and the underlyingsignaling mechanisms in a rat model of diabetes mellitus. [pubmed:27721485]
Obesity surgery The Effects of Duodenojejunal Omega Switch in Combination with High-Fat Diet and Control Diet on Incretins, Body Weight, and Glucose Tolerance in Sprague-Dawley Rats. [pubmed:28840471]
Obesity Surgery  Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague … [Pubmed:29098544]
BioMed Research International Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity []
Diabetes Research and Clinical Practice Low AS160 and high SGK basal phosphorylation associates with impaired incretin profile and type 2 diabetes in adipose tissue of obese patients [Pubmed: 31734225]
OBESITY SURGERY The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats [Pubmed: 31701411]
FUTURE SCIENCE Prediction scale of response to liraglutide therapy as the method for increase of treatment efficacy in type 2 diabetes [Pubmed:35251693]
留言咨询
Baidu
sogou